Desperately seeking hepatitis C virus

Moreno-Otero, Ricardo; Tarantino, Giovanni; Lakatos, Peter L.; Nakajima, Hisato
May 2008
World Journal of Gastroenterology;5/14/2008, Vol. 14 Issue 18, p2946
Academic Journal
Spanish investigators described recently the so-called occult hepatitis C virus (HCV) infection, emphasizing the detection of genomic and antigenomic HCV RNA strands in liver and peripheral blood mononuclear cells. Therefore, the persistence of viral replication in occult HCV infection should be considered as a putative source of infection among family members and patients undergoing invasive procedures, transfusion or transplantation. Additionally, the most worrisome finding is that an occult HCV infection may persist in patients with sustained virological response.


Related Articles

  • Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. Koike, Kazuhiko // Journal of Gastroenterology;2002 Supplement 13, Vol. 37, p55 

    Over the past decade, genetically engineered mouse models have been used for studies of the mechanisms underlying human diseases. One advantage of these models is that the targeted protein executes its function in normal cells in their natural tissue microenvironments. Transgenic mouse models...

  • Modulation of RANTES expression by HCV core protein in liver derived cell lines. Ruggieri, Anna; Franco, Marina; Gatto, Ilaria; Kumar, Ajit; Rapicetta, Maria // BMC Gastroenterology;2007, Vol. 7, p21 

    Background: Hepatitis C virus (HCV) infection is associated with high percentage of chronicity which implies the ability of the virus to evade or modulate host cell immune system. Modulation of chemokines, such as RANTES may be part of the virus induced pathogenicity. We examined the effect of...

  • Non-Organ-Specific Autoantibodies in Hepatitis C Virus Infection: Do They Matter? Boqdanos, Dimitrios-Petrou; Mieli-Verqani, Giorgina; Vergani, Diego // Clinical Infectious Diseases;2/15/2005, Vol. 40 Issue 4, p508 

    This article reports that hepatotropic viruses, such as hepatitis B virus and hepatitis C virus (HCV), can take up permanent residence in the liver and cause serious chronic disease. These viruses are noncytopathic--viral clearance is performed by the host immune response and is associated with...

  • Factors Associated with Interest in Initiating Treatment for Hepatitis C Virus (HCV) Infection among Young HCV-Infected Injection Drug Users. Strathdee, Steffanie A.; Latka, M.; Campbell, J.; O'Driscoll, P. T.; Golub, E. T.; Kapadia, F.; Pollini, R. A.; Garfein, R. S.; Thomas, D. L.; Hagan, H. // Clinical Infectious Diseases;4/15/2005 Supplement, Vol. 40, pS304 

    Objective. We sought to identify factors associated with interest in receiving therapy for hepatitis C virus (HCV) infection among HCV-infected injection drug users (IDUs) in 3 United States cities. Methods. IDUs aged 18-3 5 years who were HCV-infected and seronegative for human immunodeficiency...

  • Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection. Alter, Miriam J.; Seeff, Leonard B.; Bacon, Bruce R.; Thomas, David L.; Rigsby, Michael O.; Di Bisceglie, Adrian M. // Annals of Internal Medicine;11/2/2004, Vol. 141 Issue 9, p715 

    In the United States, chronic hepatitis C virus (HCV) infection affects an estimated 3 million persons, most younger than 50 years of age. It is one of the leading causes of chronic liver disease morbidity and mortality and the most common indication for liver transplantation. Effective...

  • Hepatitis C.  // Encyclopedic Reference of Molecular Pharmacology;2004, p450 

    A definition of the term "hepatitis C" is presented. Hepatitis C Virus (HCV) is the causative agent of hepatitis C, identified in 1989. HCV is a positive-strand RNA virus of the Flavivirideae family, known to infect human liver. Infection may be symptomless but may cause severe liver damage...

  • In Primate Study, Host MiRNA Blocker Helps Fight Hepatitis C. Breindl, Anette // BioWorld Today;12/4/2009, Vol. 20 Issue 233, p1 

    The article discusses research which found that SPC3649, a drug that sequesters miR122 helps fight hepatitis C virus in chimpanzees. It references a study by Henrik Oerum and colleagues which appeared in the December 3, 2009 issue of "Sciencexpress." The study has revealed that the drug led to a...

  • Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis. Polyak, Stephen J.; Sullivan, Daniel G.; Austin, Michael A.; Dai, James Y.; Shuhart, Margaret C.; Lindsay, Karen L.; Bonkovsky, Herbert L.; Di Bisceglie, Adrian M.; Lee, William M.; Morishima, Chihiro; Gretch, David R. // Virology Journal;2005, Vol. 2, p41 

    Background: Hepatitis C virus (HCV) circulates as quasispecies (QS), whose evolution is associated with pathogenesis. Previous studies have suggested that the use of thermostable polymerases without proofreading function may contribute to inaccurate assessment of HCV QS. In this report, we...

  • Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence. Aaron, Sagiv; McMahon, James M.; Milano, Danielle; Torres, Leilani; Clatts, Michael; Tortu, Stephanie; Mildvan, Donna; Simm, Malgorzata // Clinical Infectious Diseases;10/1/2008, Vol. 47 Issue 7, p931 

    Intranasal transmission of hepatitis C virus (HCV) via contaminated drug-sniffing implements is a potential but unconfirmed source of viral infection. We demonstrate the virological plausibility of intranasal transmission by confirming that blood and HCV RNA are present in the nasal secretions...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics